Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation

Detalles Bibliográficos
Autores principales: Iesari, Samuele, Lai, Quirino, Favi, Evaldo, Pisani, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368161/
https://www.ncbi.nlm.nih.gov/pubmed/28332381
http://dx.doi.org/10.3349/ymj.2017.58.3.679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368161/
https://www.ncbi.nlm.nih.gov/pubmed/28332381
http://dx.doi.org/10.3349/ymj.2017.58.3.679

Ejemplares similares